BHVN

Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

About Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Details

Daily high
$51.29
Daily low
$50.41
Price at open
$50.86
52 Week High
$62.21
52 Week Low
$25.38
Market cap
4.8B
Dividend yield
0.00%
Volume
35,296
Avg. volume
1.6M
P/E ratio
-5.60

Biohaven Pharmaceutical Holding Company Ltd. News

Details

Daily high
$51.29
Daily low
$50.41
Price at open
$50.86
52 Week High
$62.21
52 Week Low
$25.38
Market cap
4.8B
Dividend yield
0.00%
Volume
35,296
Avg. volume
1.6M
P/E ratio
-5.60